Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$475,622,010
+$44,391,526 QoQ
Shares Held
396,540
-15.4% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#155
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $1,673,064,906 across 14 Drug Manufacturers - General names. LLY ranks #1 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
396,540 | $475,622,010 | |
| 2 | JNJ |
Johnson & Johnson
|
1,458,722 | $370,471,625 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,340,397 | $300,741,013 | |
| 4 | AMGN |
Amgen Inc
|
494,025 | $178,896,331 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
876,893 | $110,786,660 | |
| 6 | ABBV |
AbbVie Inc.
|
391,576 | $98,536,182 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,147,117 | $66,096,880 | |
| 8 | AZN |
Astrazeneca PLC
|
282,337 | $53,536,741 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $475,622,010 | 396,540 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $431,230,484 | 468,846 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $499,736,991 | 465,010 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $347,709,782 | 455,714 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $350,731,593 | 449,927 | Shares | Defined | 2025-08-26 | |
| 2025-03-31 | $328,005,198 | 397,144 | Shares | Defined | 2025-08-26 | |
| 2024-12-31 | $361,864,192 | 468,736 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $379,146,879 | 427,960 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $330,990,629 | 365,582 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $180,569,959 | 232,107 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $62,444,138 | 107,123 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $61,275,251 | 114,079 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $56,257,432 | 119,957 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $27,128,118 | 78,994 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $28,615,638 | 78,219 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $28,217,782 | 87,267 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $29,430,679 | 90,771 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $42,751,030 | 149,286 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $43,069,049 | 155,923 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $45,558,437 | 197,180 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $45,284,065 | 197,299 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $37,716,341 | 201,886 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $42,986,999 | 254,602 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $46,615,640 | 314,928 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $37,313,187 | 227,270 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $19,447,572 | 140,193 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||